• Biography

    C. Kyle Musgrove is a patent trial and appellate lawyer. While he is experienced in many types of patent litigation, his primary focus is on representing life sciences companies. One typical representation involves helping pharmaceutical companies navigate the patent litigation process and bring their products to market pursuant to either an ANDA or a 505(b)(2) application. Other types of representations include providing advice and litigating cases relating to biosimilar and biologics applications as well as the medical device industry.

    Perhaps most significantly, clients appreciate Kyle’s understanding that the ultimate goal of any engagement is to aid his clients in the pursuit of their business interests. Litigation is often part of that process, but, ultimately, it is merely a component of the process. And, as such, Kyle crafts litigation strategy in close consultation with clients to best achieve the client’s business goals.

    In that regard, for nearly a quarter of a century, Kyle has litigated under the Hatch-Waxman Act, particularly in the United States District Courts of Delaware and New Jersey. A number of his cases have involved products with sales exceeding $1 billion per year. Despite the high stakes, Kyle has successfully obtained judgments invalidating and/or holding non-infringed the asserted claims of patents alleged to cover those products. In some instances, his strategic approach has facilitated favorable settlements for his clients while avoiding the uncertainties and expense associated with protracted litigation.

    Kyle has litigated cases in a variety of technologies in addition to pharmaceuticals, including medical devices, nutritional supplements, vaccines, and other types of biotechnology. Additionally, Kyle has practiced before the United States International Trade Commission and litigated antitrust violations relating to allegations of “sham” litigation brought by patentees.

    Kyle also handles appellate proceedings before the United States Court of Appeals for the Federal Circuit. His experience includes briefing and arguing appeals where the underlying district court litigation was handled by other counsel.

    Yet further aspects of Kyle's practice include counseling clients regarding possible infringement or invalidity issues and transactional work relating to intellectual property (including negotiating both license and settlement agreements).

    Many of Kyle’s clients are based in countries outside the U.S. Kyle is a frequent author and is often quoted in various media outlets.

    Professional Recognition

    • Recognized as a leading patent litigator by Intellectual Asset Management (IAM) Patent 1000, Globe Business Media Group, 2019
    • Recognized as a “Life Science Star” by LMG Life Sciences, Euromoney Institutional Investor PLC, 2012-2019
  • Education and Clerkships

    • J.D., University of North Carolina at Chapel Hill, 1995, with honors; Order of the Coif; Holderness Moot Court Bench; Journal of International Law and Commercial Regulation
    • B.S., Chemical Engineering, Tulane University, 1992, Omega Chi Epsilon Honor Society
  • Admissions

    • North Carolina
    • District of Columbia
    • New York
    • U.S. Patent and Trademark Office
  • Court Admissions

    • U.S. Court of Appeals for the Federal Circuit
    • U.S. District Court for the District of Columbia